|
Low-dose granulocyte colony-stimulating factor overcomes neutropenia in the treatment of non-Hodgkin's lymphoma with higher cost-effectiveness |
Hara T, Tsurumi H, Kasahara S, Kanemura N, Yoshikawa T, Goto N, Kojima Y, Yamada T, Sawada M, Takahashi T, Oyama M, Tomita E, Moriwaki H |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Hara T, Tsurumi H, Kasahara S, Kanemura N, Yoshikawa T, Goto N, Kojima Y, Yamada T, Sawada M, Takahashi T, Oyama M, Tomita E, Moriwaki H. Low-dose granulocyte colony-stimulating factor overcomes neutropenia in the treatment of non-Hodgkin's lymphoma with higher cost-effectiveness. International Journal of Hematology 2005; 82(5): 430-436 Indexing Status Subject indexing assigned by NLM MeSH Adjuvants, Immunologic /administration & Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols /administration & Costs and Cost Analysis; Cyclophosphamide /administration & Doxorubicin /administration & Female; Granulocyte Colony-Stimulating Factor /administration & Humans; Lymphoma, Non-Hodgkin /complications /drug therapy /economics; Male; Middle Aged; Neutropenia /drug therapy /economics /etiology; Prednisolone /administration & Recombinant Proteins /administration & Retrospective Studies; Vincristine /administration & derivatives /economics; dosage /analogs & dosage /economics; dosage /economics; dosage /economics; dosage /economics; dosage /economics; dosage /economics; dosage /economics AccessionNumber 22007000883 Date bibliographic record published 15/05/2007 |
|
|
|